ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Actemra 162 mg/0.9 ml, Injektionslösung zur subkutanen Anwendung - 4 Fertigspritze(n)
63166001 Roche Pharma (Schweiz) AG
Actemra 162 mg/0.9 ml, Injektionslösung zur subkutanen Anwendung12.09.2014
  12.09.2014
Tocilizumab (L04AC07) 
WHO-DDD 
07.15.4 Fertigspritze(n)
07.15. 
A  
Yes 
IPCI
962.96Yes
    
10 %1063.70
  
7680631660014Biotechnologika
6089165 
Composition
tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml.
Packungsbestandteile
Injektionslösung zur subkutanen Anwendung 
  
 
Active AgentDose
Tocilizumabum162mg / 0.9ml
BAG: Active AgentDose
Tocilizumabum162 mg
 
Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
 
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home